ISSN : 2584-0304

Become an Author
Year - 2024Volume - 2Issue - 1Pages - 100-108

AYURVEDIC MANAGEMENT OF VATARAKTA W.S.R. TO GOUT WITH GUDUCHI KSHEERPAKA A REVIEW

 28 Feb 2024  70

About Author

Ramnani1 D1,Shah D2,Jaraje D3,
1 PG scholar, Swasthavritta Department, Smt K. C. Ajmera Ayurved Mahavidyalay, Dhule
2 HOD Swasthavritta Department, Smt K. C. Ajmera Ayurved Mahavidyalay, Dhule
3 Professor Swasthavritta Department, Smt K. C. Ajmera Ayurved Mahavidyalay, Dhule

Correspondence Address

Smt K C Ajmera Ayurved Mahavidyalay , Dhule
Contact No. : 9209119421, Email : urmilaramnani890@gmail.com

Date of Acceptance : 01 Mar 2024

Date of Publication : 27 Mar 2024

Article ID : SD-IJAY_064

How to cite this article : http://doi.org/10.55552/SDNJAY.2024.2112

Abstract

Numerous health-related concerns occur globally as a result of changes in everyone's lives, resulting in a variety of systemic diseases. One of these degenerative and chronic joint and musculoskeletal diseases that mainly affects individuals in their second and third decades of life is Vatrakta, which is a joint disease that is briefly discussed in classical Ayurvedic texts. Vatrakta and gout can be compared based on their clinical similarities. According to recent studies, the prevalence of gout has grown. Medications used to treat hyperuricaemia or gout only provide temporary relief and have a number of adverse effects, finding an effective treatment is essential. Guduchi Ksheerpaka Sevan was advised by Aacharya Charaka and Vagbhata regarding how to manage Vatrakta. For Vatrakta, the preferred medication is Guduchi (Tinospora cordifolia (Willd.) Miers ex hook. & Thoms). Ingredients are easily accessible, and the preparation process is simple and easier to consume.

Introduction

Ayurveda is an ancient science that means "knowledge of life". The objectives of Ayurveda are to safeguard the well-being of the healthy person and alleviate issues associated to illness.  Changes in the way people live, consume, and interact with the environment cause a number of health problems that spread around the world and give rise to a number of systemic disorders. Chronic and degenerative joint and musculoskeletal disorders predominantly afflict persons in their second and third decades of life. Vatrakta is one of these joint diseases. Vatrakta derives its name from the primary pathogenic components involved in illness development, Vata Dosha and Rakta Dhatu. Vata and Rakta are vitiated by two distinct etiological causes; vitiated Rakta Dhatu obstructs the path of vitiated Vata, aggravating Vata even further. Because of the subtlety and pervasiveness of Vata, as well as the liquidity and dispersibility of Rakta, it circulates throughout the body via blood vessels and becomes clogged in the joint due to the zigzag pattern, aggravating it further and causing it to get logged. This causes pain, redness, swelling, stiffness, tenderness, and burning sensations at the Angushtha Parva Sandhi (small joints) of the hands and feet and spreads throughout the body[1]. Vatrakta and gout can be compared based on their clinical similarities. Gout is a metabolic disease caused by an increase in the body's urate pool due to hyperuricaemia. It is characterized by acute and chronic arthritis caused by the deposition of sodium urate (MSU) crystals in nodules of joints and connective tissues. The metatarsophalangeal joint of the first toe is frequently implicated. Clinical symptoms include joint discomfort, swelling, and the joint rapidly becoming heated, red, and painful. [1] Hyperuricaemia is characterized as serum or plasma urate concentrations greater than 7.0 mg/dL in men and 6.0 mg/dL in women. Gout incidence in the population ranges between 0.2 and 3.5 per 1000, with a total frequency of 2-26 per 1000. According to recent study, the prevalence of gout is increasing. NSAIDs, Colchicine, Glucocorticoids, Uricosuric Agents (Probenecid, Sulphinpyrazone), and Uric Acid Synthesis Inhibitors (Allopurinol, Febuxostat) are used to treat hyperuricemia or gout. These drugs only offer temporary relief and have a number of side effects, including nausea, vomiting, diarrhea, hepatotoxicity, renal toxicity, and others. [2] Therefore, it's important to find a medication that effectively stops the disease's spread in addition to curing it.

Discussion

This review explains the conceptual part of Vatarakta and control through Guduchi Ksirpaka for a better understanding of Vatarakta and control through Guduchi Ksirpaka. Vata and Rakta are the main culprits of Vatarakta. It is primarily characterized by pain in the metatarsophalangeal joints and is clinically diagnosed by elevated serum uric acid levels. With similar clinical presentation, Vataracta may be associated with gouty arthritis.  Guduchi stems are very beneficial in treating gout as they help neutralize high uric acid levels in the body. The milk proteins lactalbumin and casein reduce serum uric acid levels. As seen in Kshirpaka, its milky white properties allow the plant to be used medicinally. It has been shown that gradually increasing the temperature of milk increases the solubility of fats and proteins, thereby improving the extraction of potentially medicinally active ingredients. Therefore, Vataracta can also be treated with Guduchi Kshirpak.

Conclusion

Due to the current sedentary lifestyle, vatarakta is one of the common diseases in daily clinical practice. Therefore, it is time to explore the role and application of Ayurvedic medicines and treatments in Vataraktha. Guduchi stems are very beneficial in treating gout as they help neutralize high uric acid levels in the body. Milk proteins lactalbumin and casein reduce serum uric acid levels, which shows that Guduchi Kshirpaka is beneficial in the treatment of vatalacta.

References

  1. Fauci, Braundwald, Kasper, Hauser, Longo, Jameson et al. Harrison’s Principles of Internal Medicine; Part 14 Disorder of the Immune system, Connective Tissue, and Joints; section 3 Disorder of Joints and Adjacent tissues; Chapter 327 Gout and Other Crystal Associated Arthropathies; Volume 2nd, 17th edition, United States of America, McGraw-Hill Companies, Inc. 2008 pg no 2165
  2. Md Tanzil Ansari, Sukumar Ghosh, & Shailendra Kumar Singh. (2021). A Comparative Clinical Study of Trikarshika Kwatha with and without Lifestyle Modification in the Management of Vatarakta with Special Reference to Hyperuricaemia. International Journal of Ayurveda and Pharma Research, 9(Suppl1), 10-19. https://doi.org/10.47070/ijapr.v9iSuppl1.2106
  3. Charaka, Charaka Samhita (Vidyotini Hindi Commentary). Rajeswaradatta Shastri, Kashinath Shastri, Gorakh Nath Chaturvedi, editors. 1st ed. Varanasi: Chaukhamba Bharti Academy; 2004. Chikitsa Sthana, 29/5-7.p. 820.
  4. Aacharya Yadavji Trikamji ed,Charaka Samhita (ISBN : 978-93-80326-73-3) of Agnivesha,Chakrapani Datta, s Ayurveda deepika(sans),chikitsa sthana,vatashonita chikitsa ,29/8-10 ,Choukhambha Surbharti Prakashana,Varanasi,2020, p.627-628
  5. Aacharya Yadavji Trikamji ed, Charaka Samhita (ISBN : 978-93-80326-73-3) of Agnivesha,Chakrapani Datta, s Ayurveda deepika(sans),chikitsa sthana,vatashonita chikitsa ,29/12-14 ,Choukhambha Surbharti Prakashana,Varanasi,2020, p.628.
  6. Aacharya Yadavji Trikamji ed,Charaka Samhita (ISBN : 978-93-80326-73-3) of Agnivesha, Chakrapani Datta, s Ayurveda deepika(sans), Chikitsa, Vatashonita Chikitsa, 29/16-18, Choukhambha Surbharti Prakashana,Varanasi,2020, p.628.
  7. Rajeswaradatta Shastri, Kashinath Shastri, Gorakh Nath Chaturvedi, editors. Charaka Samhita,charak (Vidyotini Hindi Commentary), 1st ed. , Chikitsa,Vatashonita Chikitsa, 29/19 Chaukhamba Bharti Academy, Varanasi: 2004 ,p.822
  8.  Sushruta, Sushruta Samhita (Ayurveda tatva Sandipika Hindi Vyakhya), Vol. 1. Kaviraj Ambikadutta Shastri, editor. 1st ed. Varanasi: Chowkhamba Sanskrit Sansthana; 2007. Nidana Sthana, 1/48. p.232.
  9. Agnivesha, Charaka samhitha.  Varanasi: Chaukhambha Sanskrit Sansthan; 2002. p.988 (Cha. Chi. 29/31-32)
  10. Lakshmipati sastri, Yogratnakara, Vidyotini Hindi Commentry,  Purvardha Vatraktachikitsa , Guduchi Yoga ,7th edition, Varanasi ,Chaukhamba Sanskrit Sansthana 2002 Pg 558
  11.  Promila, Sushila Singh and Parvesh Devi, Pharmacological potential of Tinospora cordifolia (Willd.) Miers ex hook. & Thoms. (Giloy): A review, Journal of Pharmacognosy and Phytochemistry 2017; 6(6): 1644-164                                                                  http://www.phytojournal.com/archives/2017/vol6issue6/PartW/6-6-239-262.pdf
  12. Pt. Kashi Nath Shastri; Dr Gorakh Natha Chaturvedi, Agnivesha’s Carak Samhita Revised by Caraka and Drdhabala, Vidyotini Hindi Commentary, Volume 2nd Uttaradha Cha. Chi 29/71; Varanasi; Chaukhamba Bharti Prakashan, Reprint 2001 pg no 829
  13. Dr Ganesh Krishna Garde, Sartha Vagbhata Marathi translation of Astanga Hrdayam of Vagbhata, Chikitsasthana 22/ 7; Varanasi, Chaukhamba Subharati Prakashana 2019 Pg no 330
  14. Dr Ganesh Krishna Garde, Sartha Vagbhata Marathi translation of Astanga Hrdayam of Vagbhata, Sutrasthana chapter 5th Dravadravyavidnyaniyam / 22-23; Varanasi, Chaukhamba Subharati Prakashana 2019 Pg no 19
  15. Anuja Hari Gholap, Madhavi P. Mahajan, Mahesh K.Gupta. An Ayurvedic Review of Medicated Milk from Charak Samhita w.s.r. to its Internal Usage in Various Diseases. International Journal of Ayurveda and Pharma Research.2015;3 (5):1-5.
  16. Sharangadharacharya, Sharangdhara Samhita, with Deepika coomentary of Adhamalla and Goodartha Deepika of Kashirama, edited with foot-notes by Pandit Parshurama Shastri, Madhyama Khanda Chapter 1st Swarasadhyaya / 3; Varanasi; Krishnadas Academy; 2006; Pgno 137
  17. Sharangadharacharya, Sharangdhara Samhita,with Deepika coomentary of Adhamalla and Goodartha Deepika of Kashirama, edited with foot-notes by Pandit Parshurama Shastri ,  Madhyama Khanda Chapter 2nd Annapaka Prakriya / 161 Varanasi; Krishnadas Academy ; 2006;Pgno 167
  18. Sharangadharacharya, Sharangdhara Samhita,with Deepika coomentary of Adhamalla and Goodartha Deepika of Kashirama, edited with foot-notes by Pandit Parshurama Shastri , Prathama Khanda Chapter 2nd Bhaishajyakaalnirnaya /7 ; Varanasi; Krishnadas Academy ; 2006; Pgno 17
  19. Bhava Misra; Bhavaprakasa; Vidyotini hindi commentary edited by Bhrahmasankara Misra and Rupalalaji Vaisya First part, Guduchyadi varga / 10, 8th edition, Varanasi,Chaukhambha Sanskrit Bhavan,1997 pg no 269
Download PDF